|
|
Volumn 7, Issue 1, 2011, Pages 121-122
|
|
Doxorubicin encapsulated nanocarriers for targeted delivery to estrogen responsive breast cancer
a
|
|
Author keywords
Doxorubicin; Ligand receptor interaction; Liposomes; Targeting
|
|
Indexed keywords
ANTI-CANCER AGENTS;
ANTINEOPLASTIC AGENTS;
BIODISTRIBUTIONS;
BREAST CANCER;
CARRIER SYSTEMS;
CYTOTOXIC EFFECTS;
DOXORUBICIN;
ESTROGEN RECEPTOR;
HEALTHY TISSUES;
LIGAND-RECEPTOR INTERACTIONS;
LIPOSOMAL FORMULATION;
NANOCARRIERS;
TARGETED DELIVERY;
TARGETING;
CYTOTOXICITY;
HISTOLOGY;
PHOSPHOLIPIDS;
TISSUE;
LIPOSOMES;
DOXORUBICIN;
ESTROGEN RECEPTOR;
LIPOSOME;
NANOCARRIER;
NANOCAPSULE;
ARTICLE;
BREAST;
BREAST CANCER;
DRUG DELIVERY SYSTEM;
DRUG DISTRIBUTION;
NANOENCAPSULATION;
UTERUS;
UTERUS CANCER;
ANIMAL;
BREAST TUMOR;
CELL LINE;
CHEMISTRY;
FEMALE;
METABOLISM;
METHODOLOGY;
MOUSE;
TREATMENT OUTCOME;
ANIMALS;
BREAST NEOPLASMS;
CELL LINE;
DOXORUBICIN;
DRUG DELIVERY SYSTEMS;
FEMALE;
MICE;
NANOCAPSULES;
RECEPTORS, ESTROGEN;
TREATMENT OUTCOME;
|
|
EID: 79957682382
PISSN: 15507033
EISSN: 15507041
Source Type: Journal
DOI: 10.1166/jbn.2011.1231 Document Type: Article |
|
Times cited : (52)
|
|
References (4)
|
